Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
20 days) suppresses tumor development in mice and serves as an effective anticancer treatment with the potential to inhibit or delay the tumorigenicity of HCT-116 cells in an in vivo system
It has a half-life in circulation of around 30 seconds
27)19(13-21)11-15-4-2-10-22(15)31(28
Dragnev KH
PZM21 - CAS# 1997387-43-5 chloride hydrate(x) 20 days) suppresses tumor developmentPZM21 is a potent Gi activator with exceptional selectivity for OR and minimal arrestin 2 recruitment. PZM21 is an experimental opioid analgesic drug that is being researched for the treatment of pain. It is a functionally selective opioid receptor agonist which produces opioid receptor mediated G protein signaling, with potency and efficacy similar to morphine, but with less arrestin 2 recruitment. In tests on mice, PZM21 was slightly less potent